Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Gene Therapy Clinical Trial Services Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The gene therapy clinical trial services market size has expanded significantly in recent years. It is projected to grow from $1.82 billion in 2025 to $2.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.4%. The expansion observed historically can be ascribed to increasing investment in gene therapy R&D, the broadening of early-stage gene therapy pipelines, rising collaboration between biotech firms and CROs, the evolving complexity of gene therapy trial protocols, and increased regulatory scrutiny of advanced therapies.
The gene therapy clinical trial services market is projected for swift expansion over the coming years, reaching a valuation of $4.39 billion by 2030, driven by a compound annual growth rate (CAGR) of 19.1%. This anticipated growth during the forecast period stems from several factors, including a rise in late-stage gene therapy trials, greater need for global trial execution, the broadening of rare disease gene therapy initiatives, increasing reliance on digital platforms for trial management, and a heightened emphasis on faster regulatory clearances. Key trends expected within this period encompass a growing requirement for expert gene therapy trial management, the increasing embrace of decentralized and hybrid trial structures, an intensified focus on advanced cold chain and logistical assistance, the evolution of patient-centric trial designs, and a stronger commitment to services ensuring regulatory compliance and data integrity.
Get A Free Sample Report With In-Depth Market Insights:
Gene Therapy Clinical Trial Services Market Growth Factors Behind Sustained Expansion
The future expansion of the gene therapy clinical trial services market is anticipated to be driven by the rising need for personalized medicine. This medical strategy customizes treatments based on unique individual attributes like genetic makeup, biomarkers, and lifestyle choices. The growing requirement for personalized medicine stems from progress in genomics and biotechnology, allowing for more accurate therapeutic targeting. Gene therapy clinical trial services aid personalized medicine by examining patient-specific genetic profiles and adapting treatments. This involves utilizing biomarker analysis and companion diagnostics to refine therapy for every patient, thereby improving both safety and efficacy. A relevant example is from February 2024, when the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Consequently, the escalating demand for personalized medicine is a key factor pushing the expansion of the gene therapy clinical trial services market.
Gene Therapy Clinical Trial Services Market Segment Trends And Revenue Contributors
The gene therapy clinical trial services market covered in this report is segmented –
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention
Gene Therapy Clinical Trial Services Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the gene therapy clinical trial services market are concentrating on developing innovative solutions, such as the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials, to accelerate the overall trial process while upholding regulatory compliance and safety standards. A Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials is a structured framework developed to oversee patients for an extended duration, frequently up to 15 years following a CGT treatment. For example, in May 2025, Medable Inc., a US-based SaaS company, introduced a digital-first Long-Term Follow-Up (LTFU) model specifically engineered for cell and gene therapy (CGT) trials. This model supports cell and gene therapy trials by decreasing patient and site burdens while maintaining scientific rigor throughout the FDA-required 15-year monitoring period. It also improves patient access, retention, and data continuity via remote and hybrid follow-up methods, thereby enhancing the monitoring of long-term safety and efficacy.
Gene Therapy Clinical Trial Services Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Veristat LLC, Novotech Health Holdings Pte Limited, Covance Inc., PPD Clinical Research Services, PRA Health Sciences Inc.
View The Full Gene Therapy Clinical Trial Services Market Report:
Gene Therapy Clinical Trial Services Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the gene therapy clinical trial services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








